| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c756f9dc27223576ca38aab045aa6eff |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-75 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-9706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q17-00 |
| filingDate |
2000-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2005-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6239369a5cdc50c761131da988987916
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f0aef66e2e47671f3d939bd6ee393f2 |
| publicationDate |
2005-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6855325-B1 |
| titleOfInvention |
Use of hypo-osmotic saline solutions and medicine based on said solutions |
| abstract |
Treatment for preventing and limiting the release of the chemical mediators which are responsible of the starting of cutaneous inflammatory phenomena comprising administration to a patient of hypoosmotic saline solutions. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10130569-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010151044-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10226414-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015172651-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10835477-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108135825-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113975184-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10213370-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10463583-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017150988-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11096876-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3120791-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9913783-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IT-AN20100018-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10226410-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10285921-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10149806-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017079952-A1 |
| priorityDate |
1999-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |